DiscussierViking Therapeutics
Clinical-stage biopharmaceutical company developing novel therapies for metabolic and endocrine disorders, including a promising oral GLP-1 receptor agonist for obesity.
Clinical-stage biopharmaceutical company developing novel therapies for metabolic and endocrine disorders, including a promising oral GLP-1 receptor agonist for obesity.